Lung

Mesenchymal tumors

Pleuropulmonary blastoma



Last author update: 20 August 2024
Last staff update: 20 August 2024

Copyright: 2003-2024, PathologyOutlines.com, Inc.

PubMed Search: Pleuropulmonary blastoma pathology

Elizabeth Kruse, B.S., B.A.
Aliya N. Husain, M.D.
Cite this page: Kruse E, Husain AN. Pleuropulmonary blastoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lungtumorPPB.html. Accessed December 25th, 2024.
Definition / general
Essential features
  • There are 4 morphologic subtypes of PPB: I, IR, II and III
    • Type I: cystic tumor lined by benign nonneoplastic epithelial cells with a varying amount of malignant mesenchymal cells in the wall (no solid component) (Cancer 2023;129:600)
    • Type IR (R stands for regressed or regressing): similar to the cystic type I tumor but the population of malignant mesenchymal cells is not found; only benign nonneoplastic epithelium forming cysts with some immature mesenchyme in the wall (Cancer 2023;129:600)
    • Type II: combination of multicystic tumor and solid sarcomatous tumor (Children (Basel) 2019;6:86)
    • Type III: entirely solid sarcomatous tumor without cystic foci; can be necrotic or calcified (Children (Basel) 2019;6:86)
Terminology
ICD coding
  • ICD-10
    • C34.1 - malignant neoplasm of upper lobe, bronchus or lung
    • C34.2 - malignant neoplasm of middle lobe, bronchus or lung
    • C34.3 - malignant neoplasm of lower lobe, bronchus or lung
    • C34.8 - malignant neoplasm of overlapping sites of bronchus and lung
    • C34.9 - malignant neoplasm of unspecified part of bronchus or lung
  • ICD-11: 2C25.Y & XH2FY9 - other specified malignant neoplasms of bronchus or lung & pleuropulmonary blastoma
Epidemiology
Sites
  • Primarily arises from peripheral lung and pleura
Pathophysiology
Etiology
  • Germline loss of function mutations of DICER1 have been found in familial PPB and somatic mutations have been identified in others (Mod Pathol 2022;35:4)
    • DICER1 is involved in microRNA production, which helps regulate gene expression
    • With a DICER1 mutation, the dicer protein is unable to help with microRNA production, leading to abnormal gene expression (Mod Pathol 2022;35:4)
    • Currently estimated that 70% of patients with PPB have a DICER1 mutation (Mod Pathol 2022;35:4)
Clinical features
  • Often nonspecific cough, chest pain, dyspnea or abdominal pain (J Clin Med 2023;12:1918)
  • Can present with pneumothorax or pleural effusion (J Clin Med 2023;12:1918)
  • In individuals with DICER1 mutations, can see features such as macrocephaly, renal structural anomalies, retinal abnormalities, dental abnormalities and the GLOW syndrome (global developmental delay, lung cysts, overgrowth and Wilms tumor) (Mod Pathol 2022;35:4)
  • DICER1 mutations have been associated with several extrapulmonary neoplasms, such as Sertoli-Leydig cell tumor of the ovary, Wilms tumor, cystic nephroma, renal sarcoma, nasal chondromesenchymal hamartoma, nodular hyperplasia and carcinoma of the thyroid gland, pituitary blastoma, pineoblastoma and others (Clin Cancer Res 2018;24:2251)
Diagnosis
  • Chest radiograph, CT or MRI can aid in diagnosis (Children (Basel) 2019;6:86)
  • Histological analysis via biopsy or resection is gold standard for diagnosis
Radiology description
Radiology images

Contributed by Aliya N. Husain, M.D.
Cystic lesion chest CT

Cystic lesion chest CT



Images hosted on other servers:
CXR, CT PPB type III CXR, CT PPB type III

CXR, CT PPB type III

CT PPB type I - III

CT PPB type I - III

CT PPB

CT PPB

Prognostic factors
Case reports
Treatment
Gross description
  • Type I: composed of thin walled, cystic structures
  • Type II: composed of thin walled, cystic structures in addition to grossly visible solid foci in the cystic lesion (Mod Pathol 2022;35:4)
  • Type III: composed of solid, noncystic tissue and may have areas of necrosis or calcification (Children (Basel) 2019;6:86)
Gross images

Contributed by Erdener Özer, M.D., Ph.D.
Type III PPB characterized by well circumscribed whitish tan solid tumor

Type III PPB



Images hosted on other servers:
Cross section PPB type IR

Cross section PPB type IR

Cross section PPB type II

Cross section PPB type II

Microscopic (histologic) description
  • Type I: thin walled cysts lined by benign respiratory epithelium with small malignant mesenchymal cells in the walls of the cysts (Cancer 2023;129:600)
    • These primitive cells may have rhabdomyosarcomatous differentiation
  • Type IR: thin walled cysts lined by benign respiratory epithelium without the malignant cell population mentioned above (Cancer 2023;129:600)
  • Type II: areas of thin walled cysts lined by respiratory epithelium with areas of solid sheets of malignant mesenchymal cells that can appear as a spindled sarcoma, embryonal rhabdomyosarcoma or have no apparent differentiation (Children (Basel) 2019;6:86)
  • Type III: heterogeneous solid tumor that can contain several different patterns (Children (Basel) 2019;6:86, Cancer 2015;121:276)
    • Blastema-like area with hyperchromatic nuclei, high N:C ratio and mitotic bodies
    • Larger malignant sarcoma cells in myxoid background
      • Can have rhabdomyosarcomatoid, chrondrosarcomatoid or liposarcomatoid features (Cancer 1988;62:1516)
    • Foci of anaplastic cells with pleomorphic nuclei, mitotic bodies and hyaline inclusions
    • Some microscopic areas of benign nonneoplastic respiratory epithelium
Microscopic (histologic) images

Contributed by Aliya N. Husain, M.D.
Benign epithelial cyst lining

Benign epithelial cyst lining

Benign immature mesenchymal cells

Benign immature mesenchymal cells

Cyst with mature cartilage

Cyst with mature cartilage

Solid tumor with cyst

Solid tumor with cyst

Cyst with solid tumor

Cyst with solid tumor

Poorly differentiated solid tumor

Poorly differentiated solid tumor


Rhabdomyosarcomatous differentiation

Rhabdomyo-
sarcomatous
differentiation

Solid tumor with cartilage

Solid tumor with cartilage

Atypical mitotic figures

Atypical mitotic figures

Rhabdomyosarcomatous differentiation with desmin

Rhabdomyo-
sarcomatous
differentiation
with desmin

Rhabdomyosarcomatous differentiation with myogenin

Rhabdomyo-
sarcomatous
differentiation
with myogenin

Virtual slides

Images hosted on other servers:
Cystic pleuropulmonary blastoma Cystic pleuropulmonary blastoma

Cystic pleuropulmonary blastoma

Cytology description
Cytology images

Images hosted on other servers:
Aspiration cytology

Aspiration cytology

Negative stains
Molecular / cytogenetics description
  • Patients with PPB should undergo testing for DICER1 mutation
Sample pathology report
  • Right lung, lobectomy:
    • Pleuropulmonary blastoma, type IR (see comment)
    • Comment: The tumor is composed of a multicystic lesion with no solid component. It is lined by benign nonneoplastic epithelium and focally has small areas of immature mesenchymal cells in the wall of the cysts.
Differential diagnosis
Board review style question #1
Which of the following is true regarding pleuropulmonary blastoma type IR?

  1. Can metastasize to the brain
  2. Composed of both solid and cystic foci
  3. Contains a population of malignant mesenchymal cells in addition to benign nonneoplastic epithelium
  4. Does not contain any malignant mesenchymal cells
  5. Often progresses to type III PPB
Board review style answer #1
D. Does not contain any malignant mesenchymal cells. The lack of malignant mesenchymal cells is what differentiates PPB type IR from types I - III. Answer E is incorrect because type IR does not progress to type III due to its lack of malignant mesenchymal cells. Answer C is incorrect because type IR does not have malignant mesenchymal cells, although it does have a benign nonneoplastic epithelium. Answer B is incorrect because type IR does not contain any solid foci; it is purely cystic. Answer A is incorrect because type IR does not have a malignant component and therefore does not metastasize.

Comment Here

Reference: Pleuropulmonary blastoma
Board review style question #2

A 2 year old patient with no past medical history presented to the clinic with a cough that persisted for 1 month. On CT scan, a solid tumor occupying the lung was seen. After resection, the tumor was sent to pathology where the diagnosis of PPB type III was made. It was noted that the tumor had rhabdomyosarcomatoid differentiation and no chondromatoid differentiation. A picture of the tumor with an immunostain is shown above. Which staining pattern would you expect to see in this tumor?

  1. Positive desmin and S100, negative vimentin
  2. Positive MSA and S100, negative SMA
  3. Positive SMA and desmin, negative vimentin
  4. Positive vimentin and desmin, negative S100
  5. Positive vimentin and S100, negative desmin
Board review style answer #2
D. Positive vimentin and desmin, negative S100. PPB is positive for vimentin and the rhabdomyosarcomatoid component will be positive for desmin. S100 will be negative in this tumor because there is no chondromatoid component. Answers A and E are incorrect because S100 would not be positive in a tumor without chondromatoid components; furthermore, we would expect desmin and vimentin to be positive in this tumor. Answer C is incorrect because we would expect vimentin to be positive in this tumor. Answer B is incorrect because S100 would not be positive in a tumor without chondromatoid components and we would expect SMA to be positive given the tumor's rhabdomyosarcomatoid component.

Comment Here

Reference: Pleuropulmonary blastoma
Back to top
Image 01 Image 02